Navigation Links
Abbott Announces 11 Percent Increase in Quarterly Dividend
Date:2/20/2009

Company Declares 341st Consecutive Quarterly Dividend

ABBOTT PARK, Ill., Feb. 20 /PRNewswire-FirstCall/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend 11 percent to 40 cents per share.

This marks the 37th consecutive year that Abbott has increased its dividend payout and the 341st consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable May 15, 2009, to shareholders of record at the close of business on April 15, 2009.

Abbott has been named by a leading financial media outlet as one of its top five dividend stocks. Additionally, Abbott is a top performer of the S&P 500 Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for 25 consecutive years.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 69,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Abbott Expands Its Growing Medical Device Business With Acquisition of Advanced Medical Optics (AMO)
2. Abbott Announces Earnings Guidance for 2009
3. Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences
4. Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
5. Abbotts XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award
6. Abbott Hosts Conference Call for Third-Quarter Earnings
7. Abbott to Present at UBS Best of Americas Investment Conference
8. Zimmer Holdings, Inc. Announces Agreement to Acquire Abbott Spine, an Innovator in Spinal Technology
9. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
10. Abbott Begins Post-Approval Study of XIENCE V(TM) Drug Eluting Stent
11. FDA Approves Abbotts XIENCE(TM) V Drug Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Research and Markets ( ... "2015 Global Survey on Flow Cytometry Adoption ... The primary goal of this research is to ... reagents. Key information the survey seeks to collect ... cytometers, predominantly used applications for flow cytometers, respondents, ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
(Date:5/20/2015)... MA (PRWEB) May 20, 2015 This ... history, especially for lawns. US Patented Pearl’s Premium ... for lawns around the country that are coming out ... that addresses a number of major global concerns related ... the “non-grass” grass – the alternative to the standard, ...
(Date:5/20/2015)... May 20, 2015 The global genotyping ... 22.3% during the forecast period of 2015 to 2020 ... being used in drug discovery and development process and ... growth. In addition to this,heavy investments by key manufacturers ... are also propelling market growth. Browse 113 market data ...
Breaking Biology Technology:Global Survey on Flow Cytometry Adoption Trends 2015 2Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Breakthrough 4th Generation Low Maintenance Lawn Seed Offers Solution to California Drought 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 2Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 3Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 4Genotyping Market Growing at 22.3% CAGR to 2020: Research Based on Technology, Applications, Opportunities, Challenges and Key Players. 5
... SAN DIEGO , April 22 Neurocrine Biosciences, Inc. (Nasdaq: ... 2010 financial results after the Nasdaq market closes on Wednesday, April 28, ... discuss its financial results and provide a Company update Thursday morning, April ... Pacific Time ). , , , ...
... 22 As evidence of its drive to ... activity, Smith & Nephew ( SNN, LSE: SN) Orthopaedics ... its VERILAST technology for knee replacement implants. After simulating ... knee replacement, VERILAST technology produced an 81-percent reduction* in ...
... , April 22 PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI ) today ... 29 at 4:30 p.m. Eastern Time to discuss its financial results for ... quarter financial results after market close. , , ... , , , ...
Cached Biology Technology:Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2010 Financial Results 2Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 2Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 3Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 4Smith & Nephew Receives FDA 510k Clearance for a 30-year Knee 5PDL BioPharma to Announce First Quarter 2010 Financial Results and Hold Conference Call on April 29, 2010 2
(Date:4/27/2015)... , Apr. 27, 2015 NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce market, ... to pre-order customers the first week of May, 2015 ... month of May. Gino Pereira ... milestone for the company as Wocket® enters the consumer ...
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
(Date:4/13/2015)... 2015 According to a ... Market Forecast & Opportunities, 2020", the global biometrics market ... 14% till 2020. The biometrics market is garnering ... and review of biometric management systems. The constant ... with greater efficiency, are resulting in increasing installation ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... is a major obstacle for the proper treatment of patients ... of Rare Cancers was presented today by RARE CANCERS ... Oncology (ESMO) and the European Society of Pathology ... cancer patients get a timely and accurate diagnosis. The ...
... University of York scientist,s experience in seeing his partner ... him to design and synthesise new chemical agents that ... the University,s Department of Chemistry, led an international team ... the anti-coagulant heparin., Professor Smith says: ,I was sitting ...
... at the California Institute of Technology (Caltech) demonstrated a ... treatment that protected the mice from infection by a ... led by Nobel Laureate David Baltimore, have shown that ... strain of HIV found in the real world, even ...
Cached Biology News:Rare cancers: the challenge of accurate diagnosis -- press release 2From surgery to laboratory and back again 2
... NightOWL is a dedicated imaging system for ... light due to pixel size. Equipped with ... level light in animals or plants in ... circadian rhythm or Western blots. NightOWL is ...
... NovaTaq DNA Polymerase is a premium ... polymerase. This thermostable enzyme is suitable for ... ensure the highest purity and reproducible performance, ... variety of quality control assays. NovaTaq DNA ...
... The BD FACSAria cell sorter sets ... cytometry. Based on a revolutionary new ... delivers high-speed sorting and multicolor analysis. The ... sorter that incorporates a fixed-alignment cuvette flow ...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Biology Products: